The protection has widely been presumed to result from the strong PGC-1α-mediated induction of neuromuscular junction genes and, in particular of utrophin, a homolog of dystrophin that is known to be protective in DMD models. The gene discussed is PPARGC1A; the disease is Duchenne muscular dystrophy.